WFH and HFI Unite Experts to Advance Extended Half-Life Hemophilia Treatment Across North and North-East India
World Federation of Hemophilia (WFH) shared an honoring post on LinkedIn:
”It was an honor to join the President of the World Federation of Hemophilia (WFH), the President of Hemophilia Federation (India) Mr Premroop Alva, and Dr. Cecil Ross (Hematologist, St. John’s Hospital, Bangalore and VP–Medical, HFI) in organizing a combined event at Hotel Le Meridien, Windsor Place, Janpath Road focused on Hemophilia treatment using extended half-life (EHL) products for the North and North-Eastern regions of India.
We were privileged to have eminent experts with us:
Dr. Alok Shrivastava – Renowned Hematologist in India and World
Dr. Nita Radhakrishna – Pediatric Hematologist, PGI Noida
Dr. Shashikant Apte – Hematologist, Sahyadri Hospital, Pune
Dr. Mukul Aggarwal – Hematologist, AIIMS Delhi
Dr. Vipin Kulkarni – ICMR, Mumbai
…and many other dedicated doctors from Hemophilia Treatment Centres receiving humanitarian aid support.
Special thanks to Dr. Steven Pipe and Dr. Jay Martin (Head, WFH Humanitarian Aid Programme), Mr Harshal Kale for their leadership, along with the President of HFI, the technical team, HFI staff, and WFH colleagues for making this event possible.
As CEO of HFI, I am proud to be on the path of raising awareness, building capacity among healthcare providers, and advancing better hemophilia treatment and care across India.”
Stay updated with Hemostasis Today.
-
Aug 16, 2025, 17:35Join the Genicular Artery Embolization (GAE) Summit!
-
Aug 16, 2025, 14:00Iron Deficiency in Polycythemia Vera: William Aird Reveals JAK2-Driven Erythropoiesis as The Key Cause
-
Aug 15, 2025, 23:36Irene M Lang's Editorial on Getting Risk Assessment Right in Acute Pulmonary Embolism
-
Aug 15, 2025, 23:31Richard Buka: Many Improvements Needed in HIT Management
-
Aug 15, 2025, 23:29Cathy Harrison: Launching A Journal Club from EAHAD and WFH
-
Aug 16, 2025, 16:33RPTH Journal: Dietmar Fries and Colleagues Explore Impact of Long-Distance Trail Running on Blood Markers
-
Aug 16, 2025, 16:15Josepha Clara Sedzro: First Cryo-EM Structure of the Coagulation Initiation Complex
-
Aug 16, 2025, 15:03Abdulla Damluji Highlights ASPREE Trial Update
-
Aug 16, 2025, 14:54Wolfgang Miesbach Highlights CRISPR-Cas9 Off-Target Safety in Human Genome Editing
-
Aug 16, 2025, 13:42LMWH Use for VTE Prophylaxis in COVID-19 Hospitalized Patients - Multicenter Data from China
-
Aug 16, 2025, 14:42Mark Crowther Honors Davide Matino for Leading Promising Hemophilia Trial at McMaster University
-
Aug 14, 2025, 10:28Impressive 95% Clot Removal in a VTE Case: Symphony16F and Symphony24F Catheters
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Aug 16, 2025, 14:18Christelle Orlando Highlights Breakthroughs in Thrombophilia Testing and AT Assays at ISTH 2025
-
Aug 15, 2025, 23:33Kacper Odziomek Excels in 2 Pharmacology Courses from Harvard Medical School
-
Aug 15, 2025, 03:44Call for Global Action on Bleeding Disorders from Baumann, Christoforou and Klamroth
-
Aug 14, 2025, 02:08Jordan Harry's Conversation on Cancer and Clot Risk with Thrombosis Canada
-
Aug 13, 2025, 15:50Will Parsons Honors National Leaders in Hematology: Drs. Fasipe, Powers and Tubman